Publication
Complete hematological and major molecular response through treatment with low-dose Interferon alpha 2a in high-risk polycythemia vera patient: a case report
Journal Paper/Review - Oct 6, 2021
Driessen Christoph, Noppen Christoph, Boonen Georg, Drewe Juergen
Units
PubMed
Doi
Citation
Driessen C, Noppen C, Boonen G, Drewe J. Complete hematological and major molecular response through treatment with low-dose Interferon alpha 2a in high-risk polycythemia vera patient: a case report. Clin Case Rep 2021; 9:e04903.
Type
Journal Paper/Review (English)
Journal
Clin Case Rep 2021; 9
Publication Date
Oct 6, 2021
Issn Print
2050-0904
Pages
e04903
Brief description/objective
Low-dose interferon-α 2a treatment may be considered as an alternative to cytoreductive therapy with hydroxyurea or regularly dosed interferon in high-risk polycythemia vera patients.